About Viral Alkalis Limited
Data last updated: 06 February 2026
Viral Alkalis Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in specialty chemicals, a part of the broader chemicals and materials sector. Incorporated on 15 September 1994, the company has been in operation for over 32 years.
Registered with ROC Mumbai under CIN U24100MH1994PLC081124.
Capital: an authorised share capital of ₹40 Lakh and a paid-up capital of ₹37.83 Lakh. Formerly known as Viral Alkalis Private Limited. It is led by directors including Vinati Saraf Mutreja and Vinod Banwarilal Saraf.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Parineecrescenzo Awing 11Thfloor 1102 Gblock Plotno.C – 38&C – 39 Bkc Bandraeast, Mumbai, Maharashtra, India – 400051.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.71 Cr, a decline of 10% compared to the previous year.
The company has a workforce of approximately 39 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Viral Alkalis Limited. As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹1.19 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website viralalkalis.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressParineecrescenzo Awing 11Thfloor 1102 Gblock Plotno.C – 38&C – 39 Bkc Bandraeast, Mumbai, Maharashtra, India – 400051
-
IndustryChemicals and Materials, Specialty Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Viral Alkalis Limited
Viral Alkalis Limited has one previous CIN (Corporate Identification Number): L24100MH1994PLC081124. The current CIN is U24100MH1994PLC081124, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100MH1994PLC081124 | Current |
| L24100MH1994PLC081124 | Previous |
Associated Brands with Viral Alkalis Limited
Viral Alkalis Limited operates one associated brand: Viral Alkalis Limited. These brands represent Viral Alkalis Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of inorganic chemicals, including Potassium and Sodium Bicarbonate, from Maharashtra. | viralalkalis.com |
Business Activity of Viral Alkalis Limited
Viral Alkalis Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Viral Alkalis Limited
Viral Alkalis Limited is audited by A D AND CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A D AND CO | blur-value | blur-value | blur-value |
Board of Directors of Viral Alkalis Limited
Viral Alkalis Limited is currently managed by 5 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Vinati Saraf Mutreja
Also directs:
Vinati Organics Limited, Suchir Chemicals Private Limited, Nishit Pharma Chem Private Limited and 4 more
|
Director | 14 Apr 2006 | 20 Years 2 Months | Current |
|
Vinod Banwarilal Saraf
Also directs:
Vinati Organics Limited, Suchir Chemicals Private Limited, Nishit Pharma Chem Private Limited and 1 more
|
Director | 15 Sep 1994 | 31 Years 9 Months | Current |
|
Viral Mittal Saraf
Also directs:
Vinati Organics Limited, Suchir Chemicals Private Limited, Nishit Pharma Chem Private Limited and 4 more
|
Director | 04 Nov 2010 | 15 Years 8 Months | Current |
| Sunil Banwarilal Saraf | Managing Director | 01 Sep 2015 | 10 Years 10 Months | Current |
| Kavita Saraf | Whole-Time Director | 15 Sep 1994 | 31 Years 9 Months | Current |
Financials of Viral Alkalis Limited FY 2025 filings available
Viral Alkalis Limited reported revenue of ₹29.71 Cr (down 10% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Viral Alkalis Limited
As of FY 2023, Viral Alkalis Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Group Structure of Viral Alkalis Limited
Viral Alkalis Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Viral Alkalis Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Veeral Additives Private Limited | U24100MH2007PTC174331 |
**.**%
|
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Viral Alkalis Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2019 | Hdfc Bank Limited | ₹2 Cr | Open |
| 29 Apr 1996 | State Bank of India | ₹10 Lakh | Satisfied |
| 26 Jul 1995 | The Maharashtra State Financial Corp. | ₹88.8 Lakh | Satisfied |
| 31 Mar 1995 | The Maharashtra State Financial Corp. | ₹20 Lakh | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Viral Alkalis Limited
Viral Alkalis Limited has a workforce of 39 employees as of Mar 29, 2024.
Employee Count & EPFO Data of Viral Alkalis Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Viral Alkalis Limited
GSTIN & GST Filing Data of Viral Alkalis Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Viral Alkalis Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Viral Alkalis Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Viral Alkalis Limited
MSME Payment Delays by Viral Alkalis Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Viral Alkalis Limited
Subsidiaries & Group Companies of Viral Alkalis Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Viral Alkalis Limited with ownership details.
MCA Filings & Documents of Viral Alkalis Limited
MCA Filings & Documents of Viral Alkalis Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Viral Alkalis Limited
Frequently Asked Questions about Viral Alkalis Limited
Viral Alkalis Limited is an active public limited company in the chemicals and materials sector based in Mumbai, Maharashtra, India. It was incorporated on 15 September 1994 (32+ years old) and is registered under CIN U24100MH1994PLC081124. The company has 39 employees.
Viral Alkalis Limited reported revenue of ₹29.71 Cr for FY 2025 (down 10.00% YoY).
The current directors of Viral Alkalis Limited are:
The primary industry of Viral Alkalis Limited is chemicals and materials. The company specifically operates in specialty chemicals. The company is currently active in this sector.
Viral Alkalis Limited can be reached at the registered office: Parineecrescenzo Awing 11Thfloor 1102 Gblock Plotno.C – 38&C – 39 Bkc Bandraeast, Mumbai, Maharashtra, India – 400051, or through the website viralalkalis.com.
The authorised capital is ₹40 Lakh, and the paid-up capital is ₹37.83 Lakh.